Nanopharm
Cwmbran, United Kingdom nanopharm.co.uk
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
Nanopharm is a pharmaceutical CRO focused on developing orally inhaled and nasal drug products for small molecules and biologics. It supports customers with product development, analytical testing, in-silico modeling, regulatory consultancy, and clinical trial manufacturing services. The company is based in Cwmbran, United Kingdom, and operates as part of Aptar Pharma.
Services
Product Development
Develops nasal and inhaled drug products from preformulation and preclinical work through formulation and clinical development.
Preformulation & Preclinical
Studies drug substance properties, critical material attributes, excipients, solubility, stability, permeability, and preclinical models for OINDPs.
Spray Drying & Particle Engineering
Uses spray drying and particle engineering to control particle size, morphology, solubility, and other powder properties for OINDPs.
Formulation & Drug Product Development
Develops intranasal and inhaled formulations and combines formulation, device, and analytical studies to design complete drug products.
Clinical Development
Supports progression of OINDPs into clinical stages and commercialization with cGMP-oriented development services.
Clinical Trial Manufacturing
Provides clinical trial materials manufacturing support through Aptar Pharma Services' Boonton site for Phase 1 and 2 OINDP programs.
CDMO: development & manufacturing
cGMP Release & Stability Testing
Performs cGMP analytical release and stability testing for inhaled and intranasal drug products, including method development and validation.
Assays & in vitro testing
Clinical Labeling
Provides open and blinded labeling of clinical supplies for clinical studies.
Analytical Services
Offers analytical development and cGMP testing for inhaled and nasal drug products, including spray characterization and method development.
Assays & in vitro testing
Research & Development
Conducts analytical R&D to characterize APIs, excipients, formulations, devices, and spray properties for OINDP development.
Assays & in vitro testing
Spray Characterization
Measures spray pattern, plume geometry, particle or droplet size distribution, delivered dose uniformity, and aerodynamic particle size distribution.
Assays & in vitro testing
Method Development
Develops and validates analytical methods for R&D and cGMP testing of nasal and inhaled drug products.
Assays & in vitro testing
IVBE & CMC Studies
Supports in-vitro bioequivalence and chemistry, manufacturing, and controls studies for OINDPs.
Assays & in vitro testing
Alternative Bioequivalence
Develops non-clinical alternative bioequivalence approaches for orally inhaled and nasal drug products.
Assays & in vitro testing
In-Silico Modeling
Uses in-silico modeling tools to simulate pharmacokinetics and regional deposition for inhaled and nasal products.
PBPK Modeling
Builds physiologically based pharmacokinetic models to predict clinical PK and support OINDP development.
Regional Deposition Modeling
Models regional deposition of delivered dose in the nose or lungs using in-silico tools.
Regulatory Consultancy
Provides regulatory support for drug-device combination products and alternative regulatory pathways.
Capabilities
- Assays and studies
- Stability studies · PK/PD · Small molecules · Analytical development · Spray pattern · Plume geometry · Particle size distribution · Droplet size distribution · Delivered dose uniformity · Aerodynamic particle size distribution · Single actuation content · Dissolution
12 more
Solubility testing · Degradation pathway analysis · Compatibility testing · Pharmacokinetic simulation · Analytical testing · In-vitro testing · In-silico modeling · Pharmacokinetic simulations · Stability testing · Release testing · Method development · Spray characterization - Scale and capacity
- 8L pilot scale mixing and filling line · cGMP pilot scale · Phase 1 and 2 cGMP fill and finish services · cGMP cleanrooms · Phase 1 and Phase 2 clinical trial manufacturing · High-potency API suites · Biologics capabilities
- Therapeutic areas
- Respiratory · Nasal · Central nervous system
Instruments and platforms
- Morphologically Directed Raman Spectroscopy (MDRS)
- Aeronose® Nasal CAST 3D
- SmartTrack™
- Simhalation
Modalities and species
- Modalities
- Small molecule
- Species and models
- Preclinical or animal models · Human nasal cavity · Lungs
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: analytical testing, release and stability testing, clinical development support
Company
- Type
- CRO
- Founded
- 2002
Locations
- Based in
- Cwmbran, United Kingdom
- Sites
- Cwmbran, United Kingdom · Boonton, United States · Boonton, New Jersey, United States
- Serves
- United Kingdom, United States, global
Contacts
- Phone
- +44 (0) 1633 372200
Similar labs
Work here? Claim this listing